Bladder (Urothelial, Transitional Cell) Cancer Clinical Trials

34 clinical trials for Bladder (Urothelial, Transitional Cell) Cancer across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Distance-Based Exercise to Preserve Function and Prevent Disability — RECRUITING · NA
• DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC — RECRUITING · PHASE3
• Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients — RECRUITING · PHASE1
• Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer — RECRUITING · PHASE3
• MICROBIOTA AND BLADDER CANCER — RECRUITING · NA
• Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT — RECRUITING
• Selecting Hypoxic Tumours for Treatment Modification — RECRUITING
• Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma — RECRUITING
• Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer. — RECRUITING · NA
• Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer — RECRUITING · PHASE3
• Chemoablation for Low-Grade Bladder Cancer — RECRUITING · PHASE2
• PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma — RECRUITING · PHASE2
• A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC — NOT_YET_RECRUITING · PHASE1
• Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC? — NOT_YET_RECRUITING · PHASE2
• A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy — WITHDRAWN · PHASE3
• A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT — WITHDRAWN · PHASE3
• A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer — NOT_YET_RECRUITING · PHASE3
• INTRAOPERATIVE BLADDER INJURY ASSESSMENT IN TURBT USING BICEP — NOT_YET_RECRUITING
• The Impact of Age and Sex on Anticipated and Experienced Pain in First-Time Outpatient Flexible Cystoscopy — NOT_YET_RECRUITING
• Phase II Prospective Cohort Study of Intravesical Recombinant Human Type 5 Adenovirus Injection for Treatment of High-Risk Non-Muscle Invasive Bladder Cancer: Evaluating Efficacy and Safety — NOT_YET_RECRUITING · PHASE2
• Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection — COMPLETED · PHASE2
• Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer — NOT_YET_RECRUITING · PHASE1
• The Effect of Video Calls With Family Members During Operating Room Waiting on Stress, Anxiety, and Surgical Fear in Patients Undergoing Transurethral Resection of Bladder Tumor — NOT_YET_RECRUITING · NA
• A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection — NOT_YET_RECRUITING · PHASE2
• A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC. — NOT_YET_RECRUITING · PHASE1
• An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer — NOT_YET_RECRUITING · PHASE1
• Observational Clinical Study of Patients With Muscle - Invasive Bladder Cancer Undergoing Bladder Preservation Therapy After Neoadjuvant Therapy — NOT_YET_RECRUITING
• Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial — NOT_YET_RECRUITING · NA
• Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients — NOT_YET_RECRUITING · PHASE1
• Xpert Bladder Monitor: a Non-Invasive Follow-Up Tool for Detecting Relapse in High Grade or High Risk Bladder Cancer — NOT_YET_RECRUITING · NA
• Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients — COMPLETED
• Bp-MRI Based Multi-planar VI-RADS — COMPLETED
• A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies — WITHDRAWN
• Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer — COMPLETED · PHASE2

Refine this search